Company Starts up Late Stage Trial Testing Experimental WHIM Syndrome Treatment
mwooten / Pixabay

Company Starts up Late Stage Trial Testing Experimental WHIM Syndrome Treatment

According to a story from BioPortfolio, the biopharmaceutical company X4 Pharmaceuticals, Inc. has recently initiated a phase 3 clinical trial that is testing its current lead product candidate mavorixafor. This…

Continue Reading Company Starts up Late Stage Trial Testing Experimental WHIM Syndrome Treatment
Early Data Released From Phase 1B Duchenne Muscular Dystrophy Gene Therapy Trial
source: pixabay.com

Early Data Released From Phase 1B Duchenne Muscular Dystrophy Gene Therapy Trial

According to a story from BioPortfolio, the drug company Pfizer has recently presented data from its phase 1b clinical trial that tested the company's experimental gene therapy PF-06939926, which is…

Continue Reading Early Data Released From Phase 1B Duchenne Muscular Dystrophy Gene Therapy Trial
Researchers Observe First Cases of Congenital Leptin Deficiency in the Americas
lisichik / Pixabay

Researchers Observe First Cases of Congenital Leptin Deficiency in the Americas

According to a press release from the Texas Biomedical Research Institute (Texas Biomed), researchers from the Institute have identified another new genetic mutation that they believe can cause rare congenital…

Continue Reading Researchers Observe First Cases of Congenital Leptin Deficiency in the Americas

Canadian Study Indicates That Prescribing Practices of Infliximab for Ulcerative Colitis Need Amendment

Inflammatory Bowel Diseases Inflammatory bowel diseases (IBD) is the overarching term for both ulcerative colitis and Crohn's disease. In Canada, there are around 270,000 individuals living with the one of…

Continue Reading Canadian Study Indicates That Prescribing Practices of Infliximab for Ulcerative Colitis Need Amendment
Children’s National Health System Researchers Receive Grants to Develop High-Tech Diagnostic Aids
https://pixabay.com/en/technology-robot-human-hand-2025795/

Children’s National Health System Researchers Receive Grants to Develop High-Tech Diagnostic Aids

According to a press release from the Children's National Health System (a children's hospital in Washington, D.C.), two scientists from the Institution have been selected to receive federal funding grants…

Continue Reading Children’s National Health System Researchers Receive Grants to Develop High-Tech Diagnostic Aids
Scientists Identify Possible Link Between Pancreatic Cancer and Muscle Wasting Condition Cachexia
mohamed_hassan / Pixabay

Scientists Identify Possible Link Between Pancreatic Cancer and Muscle Wasting Condition Cachexia

According to a publication from EurekAlert, researchers from the University of Oklahoma College of Medicine (OUCM) recently published a study in the journal Gastroenterology suggesting how cachexia is triggered in…

Continue Reading Scientists Identify Possible Link Between Pancreatic Cancer and Muscle Wasting Condition Cachexia
Pancreatic Cancer Medication Shows Strong Promise Treating Advanced Biliary Tract Cancers
stevepb / Pixabay

Pancreatic Cancer Medication Shows Strong Promise Treating Advanced Biliary Tract Cancers

According to a publication from the Arizona BioIndustry Association, Dr. Rachna Shroff and a team of researchers from the Arizona Cancer Center are studying the use of nab-paclitaxel (a pancreatic…

Continue Reading Pancreatic Cancer Medication Shows Strong Promise Treating Advanced Biliary Tract Cancers
King’s College Research Suggests Serotonin Levels Could Predict Parkinson’s Years Before Symptoms
Source: Pixabay

King’s College Research Suggests Serotonin Levels Could Predict Parkinson’s Years Before Symptoms

According to a publication from the BBC, researchers with King's College London believe they've identified early biomarkers for Parkinson's disease that could help physicians predict who will be affected up…

Continue Reading King’s College Research Suggests Serotonin Levels Could Predict Parkinson’s Years Before Symptoms
CIRM Awards $12 Million Grant for Clinical Study of Gene Therapy for Cystinosis Patients
Skitterphoto / Pixabay

CIRM Awards $12 Million Grant for Clinical Study of Gene Therapy for Cystinosis Patients

According to a press release from the California Institute for Regenerative Medicine (CIRM), the Institute's governing body has approved a grant of nearly $12 million to University of California, San…

Continue Reading CIRM Awards $12 Million Grant for Clinical Study of Gene Therapy for Cystinosis Patients